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Summary 34	
Plasmodium parasites remodel their vertebrate host cells by translocating hundreds of 35	
proteins across an encasing membrane into the host cell cytosol via a putative export 36	
machinery termed PTEX. Previously PTEX150, HSP101 and EXP2 have been shown 37	
to be bona fide members of PTEX. Here we validate that PTEX88 and TRX2 are also 38	
genuine members of PTEX and provide evidence that expression of PTEX 39	
components are also expressed in early gametocytes, mosquito and liver stages, 40	
consistent with observations that protein export is not restricted to asexual stages. 41	
Although amenable to genetic tagging, HSP101, PTEX150, EXP2 and PTEX88 could 42	
not be genetically deleted in P. berghei, in keeping with the obligatory role this 43	
complex is postulated to have in maintaining normal blood-stage growth.  In contrast, 44	
the putative thioredoxin-like protein TRX2 could be deleted, with knockout parasites 45	
displaying reduced grow-rates, both in vivo and in vitro, and reduced capacity to 46	
cause severe disease in a cerebral malaria model. Thus, whilst not essential for 47	
parasite survival, TRX2 may help to optimise PTEX activity. Importantly, the 48	
generation of TRX2 knockout parasites that display altered phenotypes provides a 49	
much-needed tool to dissect PTEX function.  50	
  51	
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 52	
Introduction 53	
Malaria remains a global health burden, causing approximately 660,000 deaths and a 54	
further 220 million clinical cases annually (World Health Organisation, 2012). The 55	
clinical symptoms of malaria are associated with the stage when Plasmodium 56	
parasites reside within red blood cells (RBCs), with P. falciparum responsible for the 57	
largest proportion of human symptomatic infection. The pathogenicity of P. 58	
falciparum is attributable to its remarkable ability to radically remodel its host RBC; a 59	
process involving a number of sophisticated mechanisms that lead to the trafficking of 60	
hundreds of parasite proteins beyond its encasing parasitophorous vacuole membrane 61	
(PVM), with consequential structural and biochemical changes to the host cell (for a 62	
review see (Maier et al., 2009; Haase and de Koning-Ward, 2010)). The diverse roles 63	
these exported proteins play include facilitating nutrient and solute exchange as well 64	
as presenting adhesion proteins, particularly PfEMP1, on the infected RBC surface 65	
(Crabb et al., 1997; Staines et al., 2006; Nguitragool et al., 2011). The latter 66	
facilitates binding of the infected RBC to the microvasculature, thereby preventing 67	
their clearance from the spleen and additionally leading to the pathologies associated 68	
with Plasmodium infection (David et al., 1983; Duffy and Fried, 2003; Haldar and 69	
Mohandas, 2007).  70	
 71	
The discovery of a conserved pentameric PEXEL/HT motif that mediates protein 72	
export into the host RBC has enabled the ‘exportome’ of malaria parasites to be 73	
defined (Hiller et al., 2004; Marti et al., 2004). Whilst P. falciparum is predicted to 74	
export between 300-460 proteins, comparison of the orthologous proteins in other 75	
Plasmodium spp revealed they possess much smaller exportomes (Marti et al., 2004; 76	
Sargeant et al., 2006; van Ooij and Haldar, 2007; van Ooij et al., 2008; Pick et al., 77	
2011; Boddey et al., 2013). One plausible explanation for the larger exportome in P. 78	
falciparum is the expansion of protein families in this species, including those that 79	
contain Plasmodium helical interspersed subtelomeric (PHIST) family	 and DnaJ 80	
domains (Sargeant et al., 2006). Moreover, PfEMP1, which is encoded by ~60 var 81	
genes (Su et al., 1995), is only expressed in P. falciparum (Hall et al., 2005), and a 82	
large percentage of exported proteins additionally contribute to the correct 83	
presentation of this molecule on the infected RBC surface (Maier et al., 2008). 84	
However, more recent studies have revealed non-falciparum species may indeed 85	
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export a much larger number of proteins than first predicted, including a large 86	
repertoire of PEXEL-negative exported proteins (PNEPs) (Di Girolamo et al., 2008; 87	
Fernandez-Becerra et al., 2009; Pain and Hertz-Fowler, 2009; Sijwali and Rosenthal, 88	
2010; Fonager et al., 2011; Bernabeu et al., 2012; Pasini et al., 2012), with the 89	
number of putative P. berghei exported proteins now in excess of 350 (Pasini et al., 90	
2012). Regardless of the size of their respective exportomes, the presence of a 91	
functionally conserved PEXEL motif amongst Plasmodium species (Marti et al., 92	
2004; Sargeant et al., 2006; MacKenzie et al., 2008; Sijwali and Rosenthal, 2010), 93	
and the observation that exported proteins are present not only on the infected RBC 94	
surface but also in vesicular-like membranous structures in both P. falciparum and P. 95	
berghei-infected RBCs (Curra et al., 2011; Fonager et al., 2011; Ingmundson et al., 96	
2012; Pasini et al., 2012; Haase et al., 2013) suggest that protein trafficking and host-97	
cell remodeling is conserved amongst the Plasmodium spp. This intimates that 98	
exported proteins are trafficked via a common mechanism and, as the export of some 99	
proteins are essential to parasite survival (Maier et al., 2008; Ingmundson et al., 2012; 100	
Pasini et al., 2012; Haase et al., 2013), implies that the core components of the 101	
trafficking pathway will represent outstanding targets for chemotherapeutic 102	
intervention against all forms of malaria. Drugs that target these proteins should 103	
simultaneously block many key proteins that exhibit diverse functions, and thus not 104	
surprisingly, there has been considerable interest in dissecting the molecular pathways 105	
that facilitate protein export in malaria parasites. 106	
 107	
To gain access to the host cell cytosol, exported proteins must initially transverse the 108	
PVM. A large macromolecular complex has been identified at this membrane in P. 109	
falciparum that displays the characteristics predicted for a Plasmodium Translocon of 110	
EXported proteins and accordingly has been termed PTEX (de Koning-Ward et al., 111	
2009; Gehde et al., 2009). PTEX comprises HSP101, PTEX150 and EXP2, and two 112	
tentatively assigned components, PTEX88 and TRX2 (de Koning-Ward et al., 2009).  113	
The latter two proteins still require validation that they are constituents of PTEX as 114	
their identity was based on proteomic approaches that were used to identify proteins 115	
that co-affinity purified with HSP101 and PTEX150 (de Koning-Ward et al., 2009). 116	
HSP101 is a AAA+ATPase (El Bakkouri et al., 2010) and is the predicted energy 117	
source for protein unfolding prior to translocation through the pore-forming 118	
component of PTEX, which is proposed to be EXP2 based on its biochemical and 119	
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predicted structural properties (de Koning-Ward et al., 2009; Bullen et al., 2012). The 120	
functions of PTEX150 and the putative component PTEX88 remain unknown; 121	
orthologues are only found in Plasmodium (Aurrecoechea et al., 2009). The other 122	
putative component TRX2 is a small ~13 kDa protein that belongs to the thioredoxin 123	
family of proteins that acts to reduce disulphide bonds in substrate proteins via a 124	
conserved CXXC active site (reviewed in (Nickel et al., 2006)). This protein has 125	
previously been localized to the mitochondria (Boucher et al., 2006), to the PV(M) 126	
(Sharma et al., 2011) and to an unidentified structure within the parasite in 127	
conjunction with at the PV (Kehr et al., 2010).  128	
 129	
Given the suspected role of PTEX in protein export and, by association, parasite 130	
survival and virulence because certain exported proteins are essential and impart 131	
virulent attributes upon the parasite, we were interested in using a genetic approach to 132	
determine the consequence of disrupting the function of the PTEX components. We 133	
elected to do this in the rodent malaria parasite P. berghei, which would allow us to 134	
characterize and explore the role of PTEX in pathogenesis and survival in vivo across 135	
the malaria life cycle. To achieve this, we first needed to confirm that the orthologous 136	
PTEX components EXP2, HSP101 and PTEX150 co-localize and exist as a complex 137	
in P. berghei. Importantly, this provided validation that TRX2 and PTEX88 are 138	
indeed genuine components of PTEX. Second, we revealed that PTEX is expressed in 139	
other ‘zoite’ stages of the malaria life cycle, namely salivary gland sporozoites and 140	
liver merozoites. As for the blood-stage merozoites, expression as these stages would 141	
provide a mechanism for the parasite to insert PTEX into the PVM upon invasion of a 142	
new host cell (albeit RBC or hepatocyte) to rapidly facilitate protein export, which in 143	
the infected RBC stages begins shortly thereafter (Riglar et al., 2013). Finally, 144	
attempts to genetically disrupt all five PTEX components in P. berghei revealed 145	
HSP101, EXP2, PTEX150 and PTEX88 are likely core components of PTEX and 146	
hence are attractive drug targets. In contrast, we demonstrate that the fifth component, 147	
TRX2, is a non-essential accessory PTEX protein. Nevertheless, the marked growth 148	
and virulence phenotypes of parasites lacking TRX2 confirms an important blood-149	
stage role for the PTEX complex and suggests that this protein plays a key regulatory 150	
role in PTEX function. 151	
  152	
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Results 153	
PTEX components are expressed in P. berghei and exist as a complex  154	
Orthologues of the five P. falciparum PTEX components are found in the genomes of 155	
all Plasmodium spp. sequenced to date, including P. berghei (Aurrecoechea et al., 156	
2009).  A schematic showing the distinguishing features of the P. falciparum PTEX 157	
components and the corresponding proteins in P. berghei is presented in Fig. S1.  158	
Prior to determining which of the PTEX protein components are essential to P. 159	
berghei survival and PTEX function through gene knockout approaches, it was first 160	
necessary to establish that these proteins indeed form a similar complex in P. berghei 161	
and secondly to provide evidence that TRX2 and PTEX88 are genuine constituents of 162	
PTEX. To do this, a series of transgenic P. berghei ANKA parasite lines were created 163	
in which each of the genes encoding the five endogenous putative P. berghei ANKA 164	
(Pb) PTEX components were tagged with a triple haemagluttinin (HA)/single 165	
streptactin II epitope tag using a 3’ replacement strategy as outlined in Fig. 1A. After 166	
positive selection with pyrimethamine, transgenic parasites were isolated and 167	
subjected to genotyping by diagnostic PCR. This analysis revealed that for each 168	
transgenic line created, the endogenous locus had been modified in the expected 169	
manner (Fig. 1B). Appropriate epitope tagging in each line was subsequently 170	
confirmed by Western blot analysis of parasite extracts harvested from the blood of 171	
infected mice. All species reacting with the anti-HA antibody migrated at 172	
approximately the predicted molecular mass of the respective protein, with no 173	
labeling observed in control P. berghei wild type (WT) lysates as expected (Fig. 1C). 174	
These transgenic parasites are hereafter referred to as Pb101-HA, Pb150-HA, 175	
PbEXP2-HA, Pb88-HA and PbTRX2-HA. While additional bands were observed in 176	
Pb150-HA lysates, they most likely represent breakdown products of 150-HA since 177	
the orthologous protein in P. falciparum is also highly susceptible to degradation (de 178	
Koning-Ward, unpublished). Rabbit polyclonal antibodies raised against recombinant 179	
P. falciparum HSP101 (anti-Pf101) and EXP2 (anti-PfEXP2) (de Koning-Ward et al., 180	
2009) also recognized single protein species of the expected molecular mass in P. 181	
berghei ANKA WT, and correspondingly greater molecular mass proteins in Pb101-182	
HA or PbEXP2-HA parasites, respectively, consistent with the addition of the epitope 183	
tags in transgenic parasites and demonstrating that these antibodies cross-react with 184	
the orthologous P. berghei protein (Fig. 1D). The reactivity of the ~26 kDa band in 185	
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PbEXP2-HA with anti-PfEXP2 indicates the presence of untagged EXP2 in the 186	
population (Fig 1D).  Importantly, these data demonstrate that the loci encoding each 187	
putative PTEX gene in P. berghei are amenable to gene targeting.  188	
Next, immunofluorescence analyses (IFA) was performed to localize the orthologous 189	
PTEX proteins in the ring-stages of P. berghei ANKA infected RBC (Fig. 2A). Both 190	
the anti-PfEXP2 antibody and anti-HA antibody co-localised in fixed smears of 191	
PbEXP2-HA, giving the same punctate labeling pattern outside the parasite periphery 192	
corroborating that EXP2 had been successfully epitope-tagged in P. berghei. This 193	
punctate localization is consistent with that observed for P. falciparum EXP2. 194	
HSP101-HA and PTEX150-HA also clearly co-localised with EXP2, using the anti-195	
EXP2 and anti-HA antibodies (Fig. 2A). Unfortunately, the anti-HSP101 antibody 196	
gave non-specific labeling in P. berghei ANKA parasites by IFA (data not shown), 197	
and could not be used for co-localisation studies.  These observations are in keeping 198	
with EXP2, HSP101 and PTEX150 associating at the PVM in P. falciparum (de 199	
Koning-Ward et al., 2009; Bullen et al., 2012). The creation of the transgenic Pb88-200	
HA line also allowed localization of PTEX88 in Plasmodium spp. for the first time, 201	
revealing that it too co-localised with PbEXP2, providing support that this protein is a 202	
PTEX component (Fig. 2A). The localization of TRX2, however, was less clear and 203	
made difficult by the fact that expression of TRX2-HA was weak. In the early ring 204	
stages we observed some co-labeling of TRX2-HA with EXP2 but more pronounced 205	
internal parasite labeling with the anti-HA antibodies (Fig. 2A). As the parasites 206	
matured, the localization of TRX2-HA appeared more towards the parasite periphery 207	
rather than PV/PVM and its localization within the parasite also more pronounced. It 208	
should be noted that P. falciparum HSP101 also labels broadly through the parasite 209	
across the asexual cell cycle (Riglar et al., 2013) but in this instance we could not co-210	
localise TRX2 and HSP101 due the lack of a P. berghei HSP101 antibody with utility 211	
for IFA. The localization of TRX2-HA within the parasite was not confined to a 212	
single structure as previously observed for TRX2-GFP (which was over-expressed 213	
from episomes under transcriptional control of a non-native promoter) (Kehr et al., 214	
2010) and may represent  TRX2-HA that is in the process of being trafficked or 215	
recycled, or alternatively may represent an additional functional role for this protein 216	
in the parasite. By schizont stages TRX2-HA displayed punctate apical labeling, 217	
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reminiscent of labeling pattern observed with other PTEX components in P. 218	
falciparum and Pb150-HA (Fig. 2B).  219	
To definitively resolve whether these five proteins, including TRX2 and PTEX88 220	
form a complex in P. berghei, protein lysates derived from the transgenic P. berghei 221	
parasites expressing HA-tagged versions of the orthologous PTEX components were 222	
used in affinity purification experiments with rabbit anti-HA and then probed with 223	
either mouse anti-HA (Fig. 3A), anti-Pf101 (Fig. 3B) or anti-EXP2 (Fig. 3C). As 224	
expected, anti-HA antibodies specifically pulled-down each of the five HA-tagged 225	
proteins, whereas no signal was detected when wild type (WT) lysate was used as a 226	
control (only the control for TRX2-HA is shown in Fig. 3A, bottom panel).  In 227	
addition, affinity purification of PTEX150-HA and EXP2-HA resulted in the co-228	
precipitation of HSP101 (Fig. 3B), and PTEX150-HA and HSP101-HA co-229	
precipitated EXP2 (Fig. 3C). These interactions are specific as no signal against 230	
HSP101 or EXP2 was detected in the elution fraction when control WT lysate was 231	
used in pull-down experiments using anti-HA antibodies (Fig 3B and Fig 3C, bottom 232	
panel). Importantly, these experiments also revealed that TRX2-HA and PTEX88-HA 233	
also specifically interacted with HSP101 (Fig. 3B) and EXP2 (Fig 3C).  234	
As the anti-PfEXP2 and anti-PfHSP101 antibodies reacted rather weakly against P. 235	
berghei lysate, we obtained additional evidence that TRX2 is a component of PTEX 236	
through proteomic approaches. Specifically, proteins from PbTRX2-HA or PbWT 237	
control lysates that affinity purified with anti-HA antibodies were separated by SDS-238	
PAGE and gel slices that were suspected to contain proteins that specifically 239	
interacted with TRX2-HA were subject to protein identification by capillary liquid 240	
chromatography coupled on-line with tandem mass spectrometry (LC-MS/MS) 241	
sequencing. Twenty-seven peptides to PTEX components (including HSP101, EXP2 242	
and PTEX88) were detected in gel slices from the TRX2-HA pull-down (Table S1) 243	
whereas no PTEX peptides were detected in the corresponding PbWT pull-down. In 244	
contrast, other non-PTEX peptides (ribosomal proteins for example) could be 245	
recovered in both the PbWT and TRX2-HA pull-downs. Together, these results 246	
confirm the specificity of the PTEX interactions with TRX2.  247	
Further corroboration that PTEX88 is a component of the PTEX complex was also 248	
obtained by creating a P. falciparum transgenic parasite line in which the C-terminus 249	
of PTEX88 is tagged with a triple HA/single streptactin II tag. As can be seen from 250	
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Fig. 4A, a band corresponding to the expected molecular weight of PTEX88-HA 251	
(~92.5kDa) was observed, validating that PTEX88 had been epitope tagged. 252	
Interestingly, a lower molecular weight band of <50 kDa was consistently observed; it 253	
remains unknown, however, if this lower band represents a degraded or processed 254	
form of PTEX88-HA. Although expression of PTEX88-HA in this transgenic line 255	
was weak, consistent with the suggestion from proteomics that PTEX88 is in much 256	
lower abundance than other PTEX components (de Koning-Ward et al., 2009), it also 257	
co-localised with PTEX150 and EXP2 in P. falciparum (Fig. 4B). Immuno-258	
precipitation with anti-HA antibodies affinity purified PfPTEX88-HA but not actin as 259	
expected. Moreover, PfPTEX88-HA affinity purified EXP2 and HSP101 in a specific 260	
manner as the corresponding pull-down performed with P. falciparum 3D7 wildtype 261	
lysate was negative (Figure 4C). Taken altogether, the above experiments provide the 262	
definitive proof that a PTEX complex exists in P. berghei and that PTEX88 and 263	
TRX2 are indeed bona fide members of this complex.  264	
 265	
Targeted disruption of each PTEX gene identifies likely core and accessory 266	
components 267	
We next attempted to functionally characterize individual components of the PTEX 268	
complex in P. berghei by attempting to generate loss-of-function mutants of all five 269	
components. For this, linear PTEX targeting vectors were transfected into P. berghei 270	
ANKA parasites on three separate occasions. These constructs are designed to 271	
recombine by double cross-over at the 5’ and 3’ targeting sequences, leading to 272	
replacement of the endogenous gene with the T. gondii DHFR-TS drug selectable 273	
marker (Fig. S2A and Fig. 5A). After positive selection with the antimalarial drug 274	
pyrimethamine, parasites transfected with the HSP101 targeting construct were never 275	
recovered, whereas parasites were obtained for PTEX150, EXP2, PTEX88 and 276	
TRX2. Genotyping by PCR diagnostic for integration at the 5’ and 3’ ends revealed 277	
PTEX150, EXP2 and PTEX88 were refractory to gene deletion in three independent 278	
gene knockout attempts (data not shown) and that parasites contained only episomal 279	
versions of the targeting construct. These results were confirmed by Southern blot 280	
analysis of genomic DNA probed with 5’ or 3’ targeting regions (Fig. S2B). Since the 281	
genes encoding HSP101, PTEX150, EXP2 and PTEX88 were all amenable to genetic 282	
targeting via 3’-replacement (Fig. 1), their refractoriness to gene deletion indicates 283	
that these four PTEX components are likely to be core translocon components whose 284	
	 10
expression is either essential for parasite survival in the blood-stages of malaria 285	
infection or required to provide a significant advantage in blood stage growth. 286	
 287	
In contrast to the other four components, we were surprised to find that transgenic 288	
parasites with a disrupted TRX2 gene (PbTRX2) could be obtained following 289	
transfection with the TRX2 targeting construct (Fig. 5A) on two independent 290	
occasions. PCRs diagnostic for integration at the 5’ (S47F/O46R) and 3’ 291	
(O47F/S48R) ends revealed integration had occurred with subsequent loss of the wild 292	
type gene (data not shown). Clonal PbTRX2 devoid of wild type contamination 293	
were subsequently generated by intravenous injection of limiting dilutions of parasites 294	
into mice and two clones from independent transfections were analysed further 295	
(PbTRX2_1 and PbTRX2_2). Southern blot analysis of genomic DNA digested 296	
with BglII and EcoRI and probed with either the 5’ or 3’ targeting sequence 297	
confirmed loss of the wild type (WT) gene, as demonstrated by absence of a 4.9 Kb 298	
band, and appearance of either a 5.8 or 1.4 Kb band, respectively, which correspond 299	
to the expected integration event (Fig. 5B).  300	
 301	
It was noted that when the ΔPbTRX2 clonal lines were used to infect Balb/c mice for 302	
genotyping analysis, these parasites grew consistently slower than WT parasites.  303	
Indeed comparative infection experiments of the parasite lines in Balb/c mice 304	
confirmed that loss of TRX2 had a significant impact on growth (Fig. 6A). Despite 305	
their delayed growth in mice, the PbTRX2 clones were ultimately able to generate 306	
high parasite loads, although from day 9 post-infection (p.i), comparative analysis 307	
between groups could no longer be accurately performed as mice infected with WT 308	
had to be humanely culled due to high parasite burdens. For example, at day 11 p.i the 309	
percentage parasitemias were 33.6  4.3, 21.3  3.2 and 24.2 2.4 for WT (45 % 310	
survival), PbTRX2_1 (100 % survival) and PbTRX2_2 (100 % survival), 311	
respectively. 312	
 313	
We reasoned that the growth delay of PbTRX2 clones in vivo may have stemmed 314	
from an altered cell cycle, or that infected RBC were being cleared more efficiently 315	
by the spleen, particularly if TRX2 contributes to the export of virulence proteins that 316	
are involved in sequestration.  To examine growth further, pure merozoite 317	
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preparations devoid of contaminating schizonts were added to fresh RBC and 318	
invasion allowed to proceed for 30 mins. Infected RBCs were then intravenously 319	
administered to mice and blood smears analysed every 2-4 hrs for the next three cell 320	
cycles (Fig. 6B). While newly invaded WT ring-stage parasites were observed 23 hr 321	
later, PbTRX2_1 took an extra 5 hrs to reinvade erythrocytes. A similar delay was 322	
observed in the second cycle, such that PbTRX2_1 now lagged around 8 hrs behind 323	
the WT parasites. Furthermore, despite similar numbers of infected RBC being 324	
administered to mice, the parasitemias of PbTRX2_1 were less than half that of WT 325	
parasites during the second cycle. Repeats of this experiment yielded very similar 326	
results (data not shown).  327	
 328	
As trophozoite and schizont stages sequester in the in vivo experiments described 329	
above, we repeated the in vitro invasion but this time continued to culture the 330	
parasites in vitro until mature schizonts formed to examine more closely what stage of 331	
the cell cycle the loss of TRX2 has its greatest impact. The most obvious delays 332	
occurred at the beginning and end of the cell cycle (Fig. 6C). At 4.5 hr post-invasion 333	
(pi), only 2.9% of WT parasites remained at early ring-stage, whereas 75% of 334	
PbTRX2_1 and 30 % of PbTRX2_2 were still at this stage. By 7.5 hr pi, the 335	
majority of WT had progressed into early trophozoite stage (73%), with no early rings 336	
remaining whereas 33% and 13 % of PbTRX2_1 and PbTRX2_2, respectively had 337	
still not moved beyond the early ring stage. Likewise, by 24 hr pi when 83% of the 338	
WT parasites had already entered the schizont stage (43 % early and 40% late 339	
schizonts), only 15% of PbTRX2_1 and 20 % of PbTRX2_2 were at a similar 340	
stage of parasite development, with low numbers of late schizonts formed, if any. 341	
However, examination of the mature schizonts used to prepare the merozoites for the 342	
in vitro invasion assay did not reveal a difference in the number of merozoites per 343	
schizont between the WT and PbTRX2_1 (Fig. 6D). 344	
 345	
As PTEX is implicated in the export of virulence proteins and infection of C57/Bl6 346	
mice with P. berghei ANKA normally causes a severe lethal form of malaria (termed 347	
experimental cerebral malaria or ECM) that is associated with a multitude of 348	
neurological symptoms and extensive underlying pathology, we also compared the 349	
virulence of WT and PbTRX2 clones in C57/Bl6 mice. Mice infected with WT 350	
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parasites rapidly succumbed to ECM around day 7 pi, whereas mice infected with the 351	
PbTRX2 clones showed a marked delay in developing ECM, if at all (Fig. 7A). The 352	
parasitemias of the infected C57/Bl6 mice were also examined and the PbTRX2 353	
clones showed delays in parasitemia similar to what was observed in Balb/c mice 354	
(Fig.s 7B and 6A). Whilst WT mice exhibited a mean parasitemia of 9.1 %  0.9 on 355	
day 6 pi (one day prior to developing ECM), by day 9 pi when all but one wild type 356	
mouse had been culled, mice infected with PbTRX2_1 exhibited a mean parasitemia 357	
of only 5.0 %  0.5  (86% survival) and mice that survived infection with 358	
PbTRX2_2 (36% survival) had a mean parasitemia of 5.6 %  1.6. (Fig. 7B). 359	
Moreover, even when the PbTRX2 clones reached higher parasitemias, this did not 360	
influence their ability to cause ECM. Although the PbTRX2 clones varied slightly in 361	
their potential to cause ECM and in their growth rates, it is important to note that both 362	
clones consistently grew significantly slower and displayed altered virulence when 363	
compared to the WT line on all occasions. The reasons for the difference between the 364	
lines is unclear but may be related to the number of times the clones had been 365	
passaged. 366	
 367	
The PTEX components are expressed throughout the malaria lifecycle 368	
To date PTEX has been associated with the export of soluble PEXEL-containing 369	
proteins in the asexual blood stages (de Koning-Ward et al., 2009), however, PEXEL-370	
containing proteins have also been identified in other stages of the malaria life cycle, 371	
namely gametocyte and liver stages (Singh et al., 2007; Silvestrini et al., 2010; 372	
Ingmundson et al., 2012). This suggests that PTEX may function at multiple stages of 373	
the parasite life cycle. With the P. berghei PTEX-HA transgenic parasites in hand 374	
created as part of this study, in combination with anti-PfPTEX antibodies, we decided 375	
to explore this further.  376	
 377	
Initially PTEX expression in P. berghei PTEX-HA transgenic parasites that had 378	
switched into gametocytes was examined. Although gametocyte development in P. 379	
berghei is only slightly longer than the ~24 hours asexual cycle, mature gametocytes 380	
can be readily distinguished from asexual stage parasites in blood smears by their 381	
size, pigment and presence of a single nucleus.  Surprisingly, PTEX150-HA, 382	
HSP101-HA and PTEX88-HA expression was not observed at the PVM in these 383	
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stages. Moreover, the expression of EXP2 at the PVM and punctate labeling of 384	
TRX2-HA within the parasite was weak (Fig. S3). From this we infer that PTEX is 385	
not functional at this stage of parasite development. However, in order to explore 386	
PTEX expression in gametocytes further, we undertook similar analysis in the P. 387	
falciparum 3D7 wildtype strain as gametocyte maturation in this species occurs across 388	
a much longer timeframe of ~9-12 days and so in contrast to P. berghei, would enable 389	
us to determine if PTEX is present in the early gametocyte stages. For this, antibodies 390	
to the early gametocyte marker Pfs16 were used to discriminate between the asexual 391	
stages and stage I/II and III gametocytes by IFA, together with the three available P. 392	
falciparum PTEX antibodies. Figure 8 reveals that EXP2, HSP101 and PTEX150 393	
were all expressed in stage I-III gametocytes, which is also in keeping with the 394	
presence of these proteins in the P. falciparum stage I-II proteome (Silvestrini et al., 395	
2010). However, already from stage I/II and even more so by stage III, labeling of the 396	
PTEX components was observed more towards the parasite periphery and within the 397	
gametocyte itself, rather than co-localising with the PVM protein Pfs16 (Fig. 8). 398	
Altogether these combined results suggest that newly synthesized PTEX components 399	
in the schizont stages of parasites that are committed to becoming gametocytes are 400	
injected into the PV upon merozoite invasion but that by the time the gametocyte has 401	
reached stage III of its development, the PTEX machinery has begun to be 402	
disassembled. The observation that EXP2 is retained for longer at the PVM of 403	
gametocytes is most likely because it has a tighter association with this membrane 404	
relative to other PTEX components (Bullen et al., 2012). Indeed by the time the P. 405	
falciparum gametocytes reach stage V, PTEX labeling is only observed within the 406	
parasite (data not shown).  Our findings also correlate with the observed enrichment 407	
of gametocyte-specific exported proteins in stage1-II gametocyte proteomes and their 408	
depletion in mature stage V gametocytes (Silvestrini et al., 2010).   409	
 410	
We also examined the expression of PTEX components during the sporozoite and late 411	
liver stages of the P. berghei lifecycle. Since PTEX150 and EXP2 had already been 412	
shown in a recent study to be present at the PVM of P. falciparum infected 413	
hepatocytes in mice engrafted with human hepatocytes (Vaughan et al., 2012), the 414	
rationale for looking at the sporozoite and liver merozoites stems from the fact that in 415	
the asexual stages PTEX is already synthesized in merozoites to ensure that PTEX 416	
can be rapidly assembled in the new host cell after parasite invasion to facilitate early 417	
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protein export (Riglar et al., 2013). Accordingly, we wanted to examine the analogous 418	
stages in the infected mosquito/liver. RT-PCR performed on RNA extracted from 419	
mosquitoes and hepatocytes infected with P. berghei ANKA wild type parasites 420	
revealed that PTEX components were transcribed in midgut sporozoites and also in 421	
late liver stages coinciding with when parasites were undergoing schizogony. (Fig. 422	
9A).  Transcription of EXP2 in particular was also observed at earlier time points of 423	
both stages of development (oocyts and 24-48h liver). This was not unexpected since 424	
EXP2 is not co-regulated with HSP101 and PTEX150 in the asexual stages, despite 425	
ending up with these components in the dense granules of merozoites and the PVM of 426	
ring stages (Bullen et al., 2012). It was surprising to find, however, two different 427	
PTEX150 transcript sizes in the liver stages as this has not been observed previously 428	
in the asexual stages and the significance of this will require further follow up. The 429	
expression of PTEX components was also examined by IFA on salivary glands 430	
sporozoites extracted from mosquitoes infected with PbANKA, Pb101-HA or Pb150-431	
HA using anti-PfEXP2 or anti-HA antibodies. This analysis demonstrated EXP2, 432	
HSP101 and PTEX150 were all expressed in this invasive parasite form (Fig. 9B). 433	
Likewise, multiple punctate staining for EXP2, HSP101 and PTEX150 was also 434	
observed in individual merozoites in the late liver stages, which upon release into the 435	
blood stream, would go on to invade erythrocytes (Fig. 9C). Thus our combined 436	
results are consistent with the proposal that PTEX is contained within invasive ‘zoite’ 437	
stages of the malaria life cycle to facilitate rapid assembly of PTEX at the PVM of a 438	
newly-invaded host cell, whether that is an erythrocyte or hepatocyte, in order to 439	
facilitate protein export. A compilation of all of the experimental evidence for PTEX 440	
expression throughout the malaria life cycle, obtained through our own experiments 441	
as outlined herein, as well as from other studies is presented in Table S2. 442	
 443	
Discussion 444	
 445	
PTEX was originally identified in P. falciparum using a range of proteomic, 446	
biochemical and cell biological approaches (de Koning-Ward et al., 2009).  That 447	
analysis and a subsequent study by Bullen et al. (2012) revealed PTEX comprises of 448	
PTEX150, HSP101 and EXP2, in addition to two tentatively assigned constituents, 449	
TRX2 and PTEX88 (de Koning-Ward et al., 2009; Bullen et al., 2012). In this study 450	
we provide evidence through the creation of novel transgenic P. berghei and P. 451	
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falciparum lines in conjunction with reciprocal immuno-precipitation experiments 452	
that PTEX88 and TRX2 are indeed bona fide members of PTEX. It should be noted 453	
that although the localization of TRX2 has not been completely resolved, the finding 454	
that it is expressed in schizonts and present during early ring stages at either the 455	
PV/PVM (Kehr et al., 2010; Sharma et al., 2011) is not inconsistent with having a 456	
role in PTEX function. Whether the presence of TRX2 at other locations infers a 457	
function additional to PTEX  is unknown, although our mass spectrometry analysis of 458	
proteins that affinity purified with TRX2-HA has so far failed to yield any obvious 459	
proteins that suggests this may be the case.  460	
 461	
We also revealed that expression of PTEX is not restricted to just the asexual stages 462	
of parasite development and this is in keeping with the observation that PEXEL-463	
containing proteins are also present at other life cycle stages. The proteome of stage I 464	
and II P. falciparum gametocytes has divulged the identity of at least 26 gametocyte 465	
PEXEL-containing proteins that are putatively exported, of which PfMdv-1/Peg3 and 466	
Pfg14_0744 have been confirmed as present in the RBC cytosol (Eksi et al., 2005; 467	
Furuya et al., 2005; Silvestrini et al., 2010). All components of PTEX are also present 468	
in this proteome, with the exception of PTEX88 (Silvestrini et al., 2010). This is 469	
again in agreement with our own proteome analysis that suggests PTEX88 is in much 470	
lower abundance than other PTEX components (de Koning-Ward et al., 2009). Our 471	
IFA results that show expression of PTEX components in stage I/II gametocytes are 472	
also consistent with the gametocyte proteome data. However, it appears that at least 473	
HSP101 and PTEX150 are already beginning to dissociate from the PVM during the 474	
early gametocyte stages as indicated by lack of co-localisation with the integral PVM 475	
protein Pfs16 and this in turn is in keeping with an apparent lack of exported proteins 476	
in the mature gametocyte proteome (Silvestrini et al., 2010).  477	
 478	
For the liver stages of parasite development, there is conflicting evidence as to 479	
whether export of proteins into the hepatocyte cytosol is PEXEL-mediated (Singh et 480	
al., 2007; Cockburn et al., 2011). While it is plausible that Plasmodium parasites can 481	
usurp the hepatocyte trafficking machinery to export its proteins into this host cell, the 482	
expression of PTEX components in salivary gland sporozoites (this study) and at the 483	
PVM in P. falciparum infected hepatocytes in mice engrafted with human 484	
hepatocytes liver-chimeric mice (Vaughan et al., 2012) suggests that at least some 485	
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parasite proteins may translocate into the host cell via this parasite-derived 486	
machinery. However, this remains to be formally proven. The expression of PTEX 487	
components in salivary gland sporozoites and merozoites of late liver stages is also 488	
analogous to the synthesis of PTEX components in blood-stage merozoites, providing 489	
a mechanism for the parasite to insert PTEX into the PVM upon invasion of a new 490	
host cell to rapidly facilitate protein export.  491	
 492	
The epitope-tagging of PTEX components in P. berghei not only confirmed these five 493	
components form a complex in this Plasmodium spp., importantly it also validated 494	
that each PTEX locus is amenable to gene targeting. Hence, as the genes encoding 495	
HSP101, PTEX150, PTEX88, and EXP2 could not be disrupted, it is likely they are 496	
either all essential or are at least required to significantly enhance parasite growth and 497	
survival. Based on the prediction that HSP101 provides the crucial energy source for 498	
protein unfolding prior to translocation through the putative pore-forming component, 499	
EXP2, it was not unexpected that HSP101 and EXP2 are essential Plasmodium 500	
proteins.  In fact, their essentiality formed one of the initial criteria for their inclusion 501	
as a putative PTEX component (de Koning-Ward et al., 2009), although for these 502	
components it was not formally proven. The lack of orthologues and distinctive 503	
protein domains for PTEX150 and PTEX88 outside the Plasmodium genus, and the 504	
inability to generate gene knockouts precludes assignment of their function at this 505	
stage. Nonetheless, based on the makeup of other translocon systems in prokaryotes 506	
and eukaryotes, which usually comprise chaperones, receptors and structural 507	
components, in addition to the pore-forming component and the molecular motor 508	
(Schnell and Hebert, 2003), we envisage that PTEX150 and PTEX88 most likely 509	
serve as structural components of PTEX or potentially act as a receptor for the cargo 510	
to dock prior to translocation across the PVM.  511	
 512	
In contrast, it was surprising that TRX2 could be successfully disrupted in P. berghei, 513	
with knockout lines demonstrating both growth and virulence phenotypes. The 514	
reduced growth rates in vivo do not appear to be the result of fewer merozoites 515	
produced per schizont. Rather, PbTRX2 parasites took longer to progress through 516	
the cell cycle (as indicated by both in vitro and in vivo experiments) and fewer 517	
PbTRX2 parasites also made it through each cycle in vivo.  Whether this is a result 518	
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of some parasites dying each cycle due to poorer nutrient uptake for example or from 519	
greater clearance of infected RBC through the spleen awaits further investigation.  520	
Interestingly, the most obvious growth delays of the PbTRX2 parasites occurred 521	
during schizont and ring stages, which correlates with when TRX2 is first expressed 522	
and when PTEX is predicted to be functional, respectively.  523	
 524	
Although repeated attempts to genetically complement PbTRX2 parasites by using a 525	
second selectable marker were unsuccessful (probably due to the initial poor health 526	
and growth of the PbTRX2 parasites), it should be noted that both independent 527	
PbTRX2 clones consistently demonstrated similar phenotypes in each assay. 528	
Unfortunately, the ability to examine the export phenotypes of the PbTRX2 clones 529	
by transfection of chimeric exported (versus non-exported) GFP reporter constructs 530	
has also been unsuccessful due to the same reasons and only recently have P. berghei 531	
PEXEL-containing proteins been identified and demonstrated to be exported. Thus, 532	
although the functional proof that TRX2 and the PTEX machinery facilitates protein 533	
export will require further experimentation that is outside the scope of this study, we 534	
can infer from these results that TRX2 is an accessory component of PTEX. Other 535	
translocons also comprise non-essential accessory components (Schnell and Hebert, 536	
2003), which help to regulate activities such as translocon assembly, its status in an 537	
open/closed configuration, and the translocation of particular proteins under certain 538	
conditions. Interestingly, both chloroplasts and mitochondria use redox signals to 539	
regulate protein translocation across their respective membranes (for a review see 540	
(Stengel et al., 2010)).  For example, in chloroplasts, redox signals modulate the 541	
formation and reduction of inter- and intra-molecular disulphide bonds of translocon 542	
components at the outer membrane to regulate protein import. Additionally, the redox 543	
state of the stroma is sensed by the translocon at the inner chloroplast membrane and 544	
when there is a high demand for redox-related proteins, the efficiency of translocation 545	
of this subset of proteins is adjusted accordingly (Stengel et al., 2009; Stengel et al., 546	
2010). As EXP2 and PTEX88 harbour numerous conserved cysteine resides (Fig S1), 547	
PTEX could also be redox regulated to adjust protein export into the host cell cytosol; 548	
TRX2 is the most obvious candidate to perform this function. Since some of the 549	
exported proteins are predicted to be involved in nutrient uptake, this could account 550	
for the PbTRX2 clones exhibiting reduced growth rates. Alternatively, TRX2 may 551	
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regulate the export of a particular subset of cysteine-rich proteins that are not essential 552	
for parasite survival but aid parasite virulence. To date, only soluble exported proteins 553	
have been associated with PTEX (de Koning-Ward et al., 2009), and to our 554	
knowledge this class of proteins in Plasmodium spp. do not contain cysteine residues. 555	
However, it remains to be ascertained whether PTEX also aids in the translocation of 556	
cysteine-rich transmembrane-containing proteins found in the infected host cell such 557	
as the RIFIN, STEVOR and PfMC-2TM super family of proteins (Lavazec et al., 558	
2006). Thus, by determining the substrates of TRX2, the putative function(s) of this 559	
thioredoxin in the PTEX complex may ultimately be revealed.  560	
 561	
In conclusion, as the PTEX constituents are expressed at multiple stages of the 562	
parasite life cycle and are putatively required for the export of hundreds of parasite-563	
derived proteins into host cells, they are likely to provide outstanding targets for anti-564	
malaria chemotherapeutic intervention. Despite the finding that TRX2 is an accessory 565	
PTEX component and thus should no longer be considered a suitable drug target 566	
(Sharma et al., 2011), its thioredoxin activity, the role of redox signals in other 567	
translocon systems, and the ability to alter TRX2 expression without causing parasite 568	
lethality all provide a much needed segue for future studies aimed at unraveling how 569	
PTEX functions. 570	
 571	
Experimental Procedures 572	
Ethics Statement 573	
All experiments involving rodents were performed in strict accordance with the 574	
recommendations of the Australian Government and National Health and Medical 575	
Research Council Australian code of practice for the care and use of animals for 576	
scientific purposes. The protocols were approved by the Animal Welfare Committee 577	
at Deakin University (Approval No: AWC A97/10 and A98/2010) and Melbourne 578	
University (Approval No: AEC 1212488). 579	
 580	
Plasmid constructs 581	
To create the vectors that were used to epitope tag the endogenous P. berghei ANKA 582	
(Pb) PTEX genes, the following cloning procedures were performed. Firstly ~2kb 583	
immediately upstream of the stop codon of PbPTEX150 (which would ultimately 584	
serve as the targeting region for homologous recombination into the PbTEX150 585	
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endogenous locus) was PCR amplified from P. berghei ANKA genomic DNA 586	
(gDNA) in roughly two equal parts using the oligonucleotides O34F/O35R (5’ 587	
targeting region) and O36F/O37R (3’ targeting region) (refer to Table S3 for 588	
oligonucleotide sequences). By sewing the two resulting PCR products together with 589	
O34F/O37R, this created a SpeI site between the two adjacent 5’ and 3’ sequences 590	
that would later be used to linearise the DNA prior to transfection. The sewn PCR 591	
product was then digested with NotI and PstI and cloned in place of the P. falciparum 592	
PTEX150 in pTEX150-HA/Str 3’ (de Koning-Ward et al., 2009). Subsequent 593	
digestion with NotI and EcoRV excised the PbTEX150-HA/Str sequence together 594	
with the downstream P. berghei DHFR-TS 3’ UTR and, after treatment with Klenow, 595	
was cloned into the pB3 vector (Waters et al., 1997) that had been digested with ClaI 596	
and treated with Klenow. As the backbone of this resulting vector contained a SpeI 597	
site, this was removed by digestion with NaeI and EcoRV that flank this site, 598	
followed by re-ligation of the plasmid, to give the final epitope tagging construct 599	
termed pB3-150-HA/Str-DT3’. From this vector all subsequent P. berghei PTEX 600	
tagging constructs were made by replacement of the PbTEX150 5’ and 3’ targeting 601	
regions using SacII/SpeI and SpeI/AvrII, respectively, with the targeting sequences of 602	
HSP101 (amplified using O38F/O39R and O40F/O41R), TRX2 (O42F/O43R and 603	
O44F/O45R), PTEX88 (O46F/O47R and O48F/O49R) and EXP2 (MK13F/MK14R 604	
and MK15F/MK16R). Prior to transfection into P. berghei ANKA parasites, all 605	
targeting constructs were linearized with SpeI to drive integration into the endogenous 606	
PTEX locus. 607	
For targeted gene deletion of the PTEX genes, fragments of the 5’ UTR and 3’ UTR 608	
that would serve as targeting regions to drive integration into the endogenous locus 609	
(de Koning-Ward et al., 2000) were PCR amplified from P. berghei ANKA gDNA 610	
using gene specific primers for HSP101 (S23F/S24R and S25bF/S26bR), EXP2 611	
(S9F/S10R and S11F/S12R), PTEX88 (S1F/S2R and S3F/S4R) and TRX2 (S5F/S6R 612	
and S7F/S8R). The 5’ UTR homologous sequences were digested with ApaI/SacII (or 613	
HindIII/SacII in the case of the PTEX88 5’ UTR), with the SacII site filled in with 614	
Klenow, and cloned into the pB3 vector that was digested with ClaI, treated with 615	
Klenow and then digested with ApaI. The 3’ UTR targeting sequences of HSP101 616	
(digested with EcoRV/NotI), EXP2 (EcoRV/SmaI), PTEX88 (EcoRV/EcoRI) and 617	
TRX2 (EcoRI/SpeI) were cloned into either the corresponding sites of pB3 containing 618	
the respective 5’UTR or in the case of EXP2 and TRX2 3’ UTRs, into the SpeI site 619	
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that had been treated with Klenow. The resulting constructs were linearized with 620	
KpnI/NotI and used to transfect P. berghei ANKA parasites. 621	
To epitope tag the endogenous P. falciparum PTEX88 gene, the last ~1kb of the 622	
PTEX88 gene minus the stop codon was PCR amplified from P. falciparum 3D7 623	
genomic DNA using the oligonucleotides MK46F/MK47R. The resulting fragment 624	
was digested with NotI/PstI and cloned in place of the P. falciparum PTEX150 in 625	
pTEX150-HA/Str 3’ (de Koning-Ward et al., 2009). 626	
 627	
Parasites and transfection  628	
The reference clone15cy1 from the P. berghei ANKA strain was used to generate all 629	
transgenic parasite lines. Transfection of parasites and selection of the transgenic 630	
parasites was performed as previously described (Janse et al., 2006). Briefly, 631	
nycodenz purified P. berghei schizonts were prepared for transfection and DNA 632	
constructs were introduced using the Nucleofector® electroporation device (Amaxa). 633	
The resulting DNA mixture was injected intravenously into 6-8 weeks old Balb/c 634	
mice and drug selection with pyrimethamine (0.07 mg ml-1) of genetically 635	
transformed parasites begun at day 1 post transfection. Clonal lines of the PbTRX2 636	
parasites were generated by intravenous injection of limiting dilutions of parasites 637	
into naïve mice.  638	
Blood stage P. falciparum 3D7 were cultured continuously and transfected as 639	
previously described (Trager and Jensen, 1976; Crabb et al., 2004). Gametocyte 640	
cultures were initiated as described in Dearnley et al (2012) (Dearnley et al., 2012). 641	
Briefly, trophozoite stage parasites at 2% parasitemia were rapidly expanded. In the 642	
following cycle, the 8-10% trophozoites were then sub-divided to 2% trophozoites in 643	
5% hematocrit. Following reinvasion (day 0), the cultures were maintained in the 644	
presence of 62.5 mM N-acetyl glucosamine to inhibit asexual replication. Giemsa-645	
stained slides were used to monitor stage progression. The medium was changed daily 646	
but no fresh erythrocytes were added. Stage I-II gametocytes were harvested on day 647	
2-4 of culture. 648	
Anopheles stephensi mosquitoes were infected with P. berghei by feeding on infected 649	
mice.  Midguts were dissected from mosquitoes 12-14 days post-feeding to collect 650	
midgut sporozoites and salivary gland sporozoites were isolated from salivary glands.  651	
Coverslips seeded with 2x105 HepG2 liver cells were grown for 18 hours and then 652	
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infected with 15000-20000 sporozoites per well.  Where required, growth media was 653	
replaced 2 hours post-infection and at 24 hour intervals thereafter. 654	
 655	
Nucleic acid analysis 656	
The genotypes of PbTRX2 clonal lines were confirmed by Southern bot analysis of 657	
gDNA isolated from infected blood. Nucleic acid probes were synthesized using the 658	
DIG PCR Probe Synthesis kit.  Detection was performed using the DIG Luminescent 659	
Detection kit (Roche) according to the manufacturer’s protocol. To detect PTEX 660	
transcripts in P. berghei ANKA parasites by RT-PCR, RNA was extracted from 661	
blood, mosquito and liver stage parasites, using the NucleoSpinTM RNA II Kit 662	
(Macherey&Nagel) followed by DNaseI (Invitrogen)-treatment. cDNA was then 663	
made using the OmniscriptTM RT Kit (Qiagen) according to the manufacturers manual 664	
(incubation at 37C for one hour). cDNA was used in PCR reactions using the 665	
oligonucleotide combinations: MK22/MK23 (PbEXP2), MK26/MK27 (PbPTEX88), 666	
MK28/MK29 (PbPTEX150), MK40/MK41 (PbHSP101), PbTRX2F/PbTRX2R 667	
(PbTRX2) and PbTubulinS/PbTublinAS or DO216F/DO217R (PbTubulin). Each RT-668	
PCR was also performed in the absence of reverse transcriptase to test RNA samples 669	
for gDNA contamination.  670	
 671	
Indirect immunofluorescence analysis (IFA) 672	
For immunofluorescence microscopy, infected erythrocytes were fixed with ice-cold 673	
90% acetone/10% methanol for 2 min, or with 0.01%/4% gluteraldehyde/para-674	
formaldehyde followed by 0.25% Triton-X 100 permeabilisation prior to blocking in 675	
1% BSA/PBS. Sporozoites were applied to BSA or poly-L lysine coated coverslips 676	
and allowed to settle for 10 minutes. Sporozoites and infected liver cells were fixed 677	
for 20 min with 4% paraformaldehyde and permeablized with ice-cold methanol. P. 678	
falciparum gametocyte fixation was performed with 100% acetone.  All antibody 679	
incubations were performed in 0.5% BSA/PBS, with the exception of sporozoite and 680	
liver cell culture and P. falciparum gametocyte IFAs, where incubations were 681	
performed in 3% BSA/PBS. Primary antibodies for P. berghei blood stages were used 682	
at the following concentrations: rabbit anti-EXP2 (1:500), rabbit anti-HSP101 683	
(1:300), rat anti-HA (1:300). For liver and sporozoite stages, rabbit anti-EXP2 was 684	
used at 1:250, rat anti-HA at 1:100, anti-PfACP at 1:500 and mouse polyclonal anti-P. 685	
berghei at 1:500. For P. falciparum these antibodies, in addition to rabbit anti-686	
	 22
PTEX150 and mouse anti-Pfs16, were used at 1:1000. After three washes with mouse 687	
tonicity PBS, the appropriate Alexa Fluor 488/568 conjugated secondary antibodies 688	
were used at 1:4000 (Molecular Probes) with DAPI (0.5 μg ml-1). Images were 689	
acquired with an Olympus IX70, Leica TCS SP2 or DeltaVision Elite microscope and 690	
images were processed using NIH ImageJ version 1.47d (www.rsbweb.nih.gov/ij) or 691	
Adobe CS6 Photoshop. 692	
 693	
Protein analysis and immuno-precipitations 694	
Infected rodent blood was depleted of leukocytes by passage through a CF11 column 695	
(Wattman) and then lysed using 0.02% saponin for 15 min on ice, followed by 696	
centrifugation at 20 000 g for 5 min. After three washes with ice-cold mouse tonicity 697	
(MT) PBS containing 1 x complete protease inhibitors (Roche), the parasite pellet was 698	
resuspended in 1x reducing sample buffer. For immunoblots, P. berghei parasite 699	
lysates were separated on a 4-12% gradient SDS-PAGE gels (Invitrogen) and 700	
transferred onto 0.45um PVDF membrane (Millipore) using SDS transfer buffer with 701	
methanol and a wet transfer blotting device (Bio-Rad). Immunoreactions were 702	
performed using antibodies in 3% BSA/PBS and detection was performed using 703	
SuperSignal enhanced chemiluminescence (Thermo Fischer Scientific).  704	
For immunoprecipations (IP), P. berghei infected RBCs depleted of leukocytes or P. 705	
falciparum infected RBC were lysed with 0.02% saponin. Pelleted parasite material 706	
(~200-300 μg) was either lysed with IP lysis buffer (Pierce) or 0.5% Triton X-100 in 707	
PBS containing complete protease inhibitors (Roche). After a 30 min incubation on 708	
ice, the material was passed ten times through a 29G insulin needle, followed by 709	
centrifugation at 21 000 g for 10 min at 4C. The supernatant was affinity purified 710	
with either goat anti-HA antibodies coupled to magnetic beads (Miltenyi Biotec 711	
Australia) as per the manufacturer’s instruction or 150 L anti-HA sepharose (Roche) 712	
for 8h at 4C. Unbound material was collected and beads then washed four times with 713	
1 mL lysis buffer and once with 1 mL PBS. Bound proteins were eluted with 50 L 714	
1x reducing sample buffer and separated by SDS-PAGE.  715	
For immuno-immune-detection primary antibodies used were monoclonal mouse 716	
anti‐HA	 (12CA5)	 (1:1000) (Roche), polyclonal rabbit anti-HSP101 (1/200 for P. 717	
berghei, 1/500 for P. falciparum), monoclonal mouse anti-HSP101 (1/500), 718	
polyclonal rabbit anti-PTEX150 (1:200 for P. falciparum), monoclonal mouse anti-719	
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EXP2 (mAb 7.7, a gift from J. McBride and described previously (21,35) (1/500 for 720	
P. berghei and 1:2,000 for P. falciparum). Secondary antibodies were horseradish 721	
peroxidase-conjugated goat anti-mouse and goat anti-rabbit antibodies  (1:2000, 722	
Jackson IR). 723	
 724	
Gel excision, in-gel digestion and Nano-LC-MS/MS 725	
Protein spots or bands were manually excised from preparative SDS-PAGE gels and 726	
subjected to manual in-gel reduction, alkylation, and tryptic digestion.  All gel 727	
samples were reduced with 10mM DTT for 30 min, alkykated for 30 min with 50mM 728	
iodoacetic acid and digested with 375ng trypsin (Promega) for 16hrs at 37C. The 729	
extracted peptide solutions were then acidified (0.1% formic acid) and concentrated to 730	
approximately 10ul by centrifugal lyophilisation using a SpeedVac AES 1010 731	
(Savant).  Extracted peptides were injected and fractionated by nanoflow reversed-732	
phase liquid chromatography on a nano-UHPLC system (Easy n-LC II, Thermo 733	
Fisher, USA) using a nanoAcquity C18 150 mm × 0.15 mm I.D. column (Waters, 734	
USA) developed with a linear 60-min gradient with a flow rate of 250 nl/min from 735	
100% solvent A (0.1% Formic acid in Milli-Q water) to 100 % solvent B (0.1% 736	
Formic acid, 60% acetonitrile, (Thermo Fisher, USA) 40% Milli-Q water). The nano 737	
UHPLC was coupled on-line to an LTQ-Orbitrap mass spectrometer equipped with a 738	
nanoelectrospray ion source (Thermo Fisher, USA) for automated MS/MS. Up to five 739	
most intense ions per cycle were fragmented and analysed in the linear trap, with 740	
target ions already selected for MS/MS being dynamically excluded for 3 min.  741	
 742	
Mass spectra database searching 743	
For protein identification of gel samples LC-MS/MS data were searched against a 744	
non-redundant protein decoy database comprising sequences from the latest version 745	
of LudwigNR (Human, Bovine, Plasmoduim falciparum species), as well as their 746	
reverse sequences (249275 entries).  Mass spectra peak lists were extracted using 747	
extract-msn as part of Bioworks 3.3.1 (Thermo Fisher Scientific) linked into Mascot 748	
Daemon (Matrix Science, UK). The parameters used to generate the peak lists for the 749	
LTQ Orbitrap were as follows: minimum mass 400; maximum mass 5000; grouping 750	
tolerance 0.01 Da; intermediate scans 1; minimum group count 1; 10 peaks minimum 751	
and total ion current of 100. Peak lists for each nano-LC-MS/MS run were used to 752	
search MASCOT v2.2.04 search algorithm (Matrix Science, UK) provided by the 753	
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Australian Proteomics Computational Facility (www.apcf.edu.au).  The search 754	
parameters consisted of carboxymethylation of cysteine as a fixed modification (+58 755	
Da, for gel samples only), with variable modifications set for NH2-terminal 756	
acetylation (+42 Da) and oxidation of methionine (+16 Da).  A precursor mass 757	
tolerance of 20 ppm, #13C defined as 1, fragment ion mass tolerance of ±0.8 Da, and 758	
an allowance for up to three missed cleavages for tryptic searches was used. 759	
 760	
Parasite Growth Curves  761	
To assess whether transgenic parasites were affected in their growth and/or replication 762	
in comparison to WT parasites, three groups of Balb/c mice were infected with 763	
asynchronous 1105 P. berghei ANKA WT (n=14) or PbTRX2-infected RBC 764	
(n=14). The parasitemia from each mouse was calculated on a daily basis from 3 days 765	
post-infection (p.i). Mice were humanely culled when parasitemias exceeded 25%.  766	
 767	
Analysis of Parasite Virulence 768	
As a measure of parasitic virulence, transgenic parasites were compared to WT 769	
parasites in their ability to cause cerebral malaria in C57Bl/6 mice. For this, three 770	
groups of six C57Bl/6 female mice at six weeks of age were infected with 1106 P. 771	
berghei ANKA WT, PbTRX2_1 or PbTRX2_2 parasites. The parasitemias from 772	
each mouse was calculated from 3 days p.i and thereafter on a daily basis. Mice were 773	
checked every 4 hours for cerebral malaria symptoms including ataxia and inability to 774	
self-right from day 5 p.i. Mice were culled at the sign of cerebral malaria symptoms 775	
or when the parasitemia exceeded 25%. Statistical analysis was performed using a 776	
two-tailed student’s t-test. 777	
 778	
In vitro and in vivo growth analysis of parasites 779	
Infected erythrocytes from Balb/C mice were cultured in complete RPMI medium 780	
supplemented with 25% FCS overnight at 36.5C. Schizonts were burst by 781	
mechanical action using a fine needle syringe.  Purification of viable merozoites was 782	
achieved by filtration through a 0.2um filter, resulting in a pure population of free 783	
merozoites.   These were then combined with reticulocyte rich blood obtained from 784	
phenylhydrazine pre-treated mice. Invasion was allowed to proceed for 30 minutes at 785	
37C with vigorous shaking, upon which the cells continued to be cultured in-vitro or 786	
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alternatively they were intravenously injected into naïve mice and monitored by blood 787	
smears at 2-4 hour intervals.   788	
 789	
Statistical analysis 790	
Graphs were generated and data analysed using GraphPad Prism 6.0b Software 791	
(MacKiev). Statistical analysis was performed using a two-tailed student’s t-test. A P 792	
value <0.05 was considered significant. 793	
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Figure legends 998	
 999	
Fig. 1. Generation of P. berghei transgenic parasites expressing epitope tags. A) 1000	
The targeting constructs were designed to integrate into the respective P. berghei 1001	
PTEX locus by single cross-over recombination, such that the complete open reading 1002	
frame was reconstituted while simultaneously introducing a combined C-terminal 1003	
triple haemagluttinin (HA) and single Strep-II (Str) epitope tag. The predicted 1004	
structure of the endogenous locus before and after 3’ integration is shown. Black box, 1005	
3xHA/Str epitope tags; SM, Toxoplasma gondii DHFR-TS selectable marker cassette; 1006	
wavy lines, plasmid backbone; right arrow, transcription start site; circle, transcription 1007	
terminator; LS, linearization site; arrowheads, oligonucleotides used in diagnostic 1008	
PCR analysis. B) Diagnostic PCR to detect integration events. Oligonucleotide 1009	
combinations a /O233R were used to detect incorporation of the epitope tags into 1010	
transgenic PbPTEX150 (150-HA), PbHSP101 (101-HA), PbTEX88 (88-HA), 1011	
PbEXP2 (EXP2-HA) and PbTRX2 (TRX2-HA), whereas oligonucleotide 1012	
combination a/b PCR up the wild type (WT) PTEX gene C) Western blot analysis of 1013	
parasite proteins extracted from WT and transgenic P. berghei parasites harvested 1014	
from infected mice using anti-HA antibodies. D) Western blot analysis of WT and 1015	
transgenic PbEXP2-HA and Pb101-HA using the indicated antibodies reveal that the 1016	
anti-PfEXP2 and anti-Pf101 recognise a predominant protein species in WT P. 1017	
berghei extracts of roughly the predicted molecular weight, while slightly higher 1018	
species are observed in the transgenic parasite lines due to the incorporation of the 1019	
epitope tags.  1020	
 1021	
Fig. 2. P. berghei PTEX components co-localise and have PV/PVM localization. 1022	
Double-labeling IFA performed on A) fixed rings stages or B) fixed schizont stages of 1023	
P. berghei PTEX-HA transgenic parasites using the antibodies as indicated. The 1024	
original magnification for all IFA images was 1,000.  1025	
 1026	
Fig. 3. The five putative PTEX components form a complex in P. berghei, 1027	
including PTEX88 and TRX2. Immunoblot analysis of immuno-precipitations (IP) 1028	
performed on P. berghei ANKA wild type (WT) and transgenic HA-tagged parasite 1029	
lysates using anti-HA antibody (-HA) for the IP and probed with A) anti-HA, B) 1030	
	 31
anti-Pf101, or C) anti-EXP2. Supernatant (SN) was collected after parasite lysate was 1031	
centrifuged and the flow fraction represents unbound supernatant material. The 1032	
presence of PTEX components in the elution fraction of immune-precipitations 1033	
performed on HA-tagged parasites and their absence in the P. berghei wildtype (WT) 1034	
control indicates the interaction is specific. Note that in the uncloned PbEXP2-HA 1035	
transgenic population the EXP2 antibody detects both epitope-tagged and untagged 1036	
EXP2 in oligomers that dynamically associate.  1037	
 1038	
Fig. 4. Epitope tagging of P. falciparum PTEX88 confirms its PVM localization 1039	
and interaction with other PTEX components. A) Western blot analysis confirming 1040	
the endogenous P. falciparum PTEX88 gene has been tagged with a combined triple 1041	
haemagluttinin (HA) and single Strep-II (Str) epitope tag at the C-terminus. B) 1042	
Double-labeling IFA performed on ring stages of P. falciparum PTEX88-HA with the 1043	
antibodies as indicated. C) Immunoblot analysis of immuno-precipitations performed 1044	
on PfTEX88-HA using -HA antibodies shows lack of interaction of PTEX88-HA 1045	
with a non-PTEX protein (actin), whereas a specific interaction is observed with 1046	
EXP2, PTEX150 and HSP101 as PTEX components are not detected in the elution 1047	
fraction of 3D7 control parasites.  1048	
 1049	
Fig. 5. The P. berghei TRX2 gene is not essential for parasite survival. A) The P. 1050	
berghei TRX2 targeting construct was designed to integrate into the endogenous locus 1051	
by double crossover recombination. The predicted structure of the endogenous locus 1052	
before and after integration is shown. 5’ Fl, 5’ targeting sequence; 3’ Fl, 3’ targeting 1053	
sequence; SM, Toxoplasma gondii DHFR selectable marker cassette; right arrow, 1054	
transcription start site; circle, transcription terminator; arrowheads, oligonucleotides 1055	
used in diagnostic PCR analysis. B) Southern blot showing homologous integration 1056	
into the PbTRX2 gene as predicted. Genomic DNA from the P. berghei ANKA wild 1057	
type (WT) and two independent PbTRX2 clones digested with restriction enzymes 1058	
as indicated and probed with either the 5’ or 3’ targeting sequence. In both cases the 1059	
endogenous locus (E) has been modified and integration bands (In) of the predicted 1060	
size are seen.  1061	
 1062	
Fig. 6. Loss of TRX2 leads to altered growth phenotypes in vivo and in vitro. A) 1063	
	 32
Growth curves of P. berghei wild type (WT) and PbTRX2 clones in Balb/c mice 1064	
(n=12). The cross indicates number of mouse deaths. Data was pooled from two 1065	
separate experiments. Error bars represent SEM. A two-tailed student’s t test was 1066	
used to calculate statistical significance. B) In vivo growth analysis of P. berghei 1067	
parasite lines in which invasion had been synchronized in vitro prior to intravenous 1068	
inoculation in mice. The solid grey and black dashed arrows indicate the timepoints at 1069	
which new invasion events of WT and PbTRX2_1, respectively could be detected. 1070	
C) In vitro growth analysis of P. berghei parasite lines following synchronous 1071	
invasion in vitro. ER, early ring; LR, late ring; ET, early trophozoite; LT, late 1072	
trophozoite; ES, early schizont; LS, late schizont. D) Column graph depicting the 1073	
number of merozoites formed per mature schizont (n=50). 1074	
 1075	
Fig. 7. Loss of TRX2 leads to altered virulence and growth phenotypes in 1076	
C57/Bl6 mice A) Survival curves (n=14) and B) growth curves of parasite lines 1077	
(n=12) in C57/Bl6 mice.  Data was pooled from two separate experiments. Error bars 1078	
represent SEM. A two-tailed student’s t test was used to calculate statistical 1079	
significance. 1080	
 1081	
Fig. 8. PTEX is expressed in stage I/II gametocytes but undergoes degradation 1082	
during gametocyte maturation. Double-labeling IFA performed on fixed P. 1083	
falciparum 3D7 gametocytes using the antibodies as indicated. Pfs16 is an integral 1084	
gametocyte specific PVM protein expressed from stages I/II of P. falciparum 1085	
gametocytes. Gametocytes in the top panel are stageI/II gametocytes, whereas those 1086	
in the bottom panel are at stage III.   1087	
 1088	
Fig. 9. PTEX is expressed during mosquito and liver stages of parasite 1089	
development A) RT-PCR of PTEX genes and tubulin (loading control) on blood, 1090	
mosquito (oocyst and midgut sporozoites) and liver stages of parasite development. 1091	
As controls, genomic DNA (gDNA) isolated from P. berghei was also used in PCR.  1092	
B) Double-labeling IFA performed on fixed salivary gland sporozoites, and C) 1093	
infected hepatocytes (~68-72 hr pi), using the antibodies as indicated, including anti-1094	
Pb (which recognizes the parasite surface) or anti-ACP (which recognizes the 1095	
apicoplast). An enlargement of the boxed region showing an individual merozoite is 1096	
	 33
shown to the right. Scale bars represent 1 m for the sporozoites and 10 M for the 1097	
infected hepatocytes. 1098	
 1099	
Supplementary Fig. 1 Schematic of the P. falciparum PTEX components and 1100	
corresponding proteins in P. berghei. Distinguishing features are highlighted. White 1101	
gaps indicate deletions of amino acid sequences relative to the corresponding protein. 1102	
The protein length in amino acids is indicated.  1103	
 1104	
Supplementary Fig. 2. HSP101, PTEX150, EXP2 and PTEX88 are refractory to 1105	
gene deletion. A) The P. berghei targeting constructs were designed to integrate into 1106	
the respective endogenous PTEX locus by double cross-over recombination. The 1107	
predicted structure of the endogenous locus before and after integration is shown. 5’ 1108	
Fl, 5’ targeting sequence; 3’ Fl, 3’ targeting sequence; SM, Toxoplasma gondii DHFR 1109	
selectable marker cassette; right arrow, transcription start site; circle, transcription 1110	
terminator; The a/c and b/d oligonucleotide combinations (represented by 1111	
arrowheads) were used in diagnostic PCR analysis to detect integration of the 5’ and 1112	
3’ targeting sequences, respectively. B) Southern blot of DNA recovered from 1113	
parasites surviving pyrimethamine selection that had been digested with the indicated 1114	
restriction enzymes and probed with either the 5’ or 3’ targeting sequence reveal that 1115	
the endogenous gene (E) remained intact and bands indicative of an integration event 1116	
(In) were not observed.  1117	
 1118	
Supplementary Fig. 3 PTEX is not functional in mature gametocytes. A) Double-1119	
labeling IFA performed on fixed gametocytes of P. berghei transgenic parasites, using 1120	
the antibodies as indicated. 1121	
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Supporting information 
Supplementary Table 1. MS data for putative P. berghei translocon components specific to TRX2-HA pull-downs 
 
Identified P. berghei 
protein  Accession#  Band #  Mr 
# peptides  
(% coverage)  # spectra 
Sequence  Mascot score (best)  Mascot Delta  Observed (Da)  Charge  Actual Mass (Da)  Delta PPM 
HSP101, putative   PBANKA_093120  10B  103 kDa  7 (9%)  13 
(K)TIVINSEGTNEVLAEAK(A)  60.53  54.93  894.4733  2  1,786.93  0.3457 
(R)AIIESLLR(Y)  43.99  15.1  457.7873  2  913.56  0.2822 
(K)TTIVEGLAYR(I)  45.18  33.97  561.8115  2  1,121.61  0.2833 
(R)GYTIISLNFR(K)  49.14  26.44  592.3277  2  1,182.64  0.9108 
(K)LIGATTVTEYR(K)  61.2  53.78  612.3354  2  1,222.66  0.2926 
(R)VIDLTER(Y)  39.93  19.28  423.2402  2  844.4658  0.3289 
(R)DSGmPLGSLSFESSK(G)  47.89  40.03  779.3591  2  1,556.70  0.4642 
PTEX88, putative  PBANKA_094130  7B  87 kDa  7 (10%)  12 
(K)LILTEQLNSISNIR(V)  68.26  42.88  807.465  2  1,612.92  0.3334 
(R)VINDESSIK(L)  33.28  27.57  502.7671  2  1,003.52  0.9537 
(K)IFSALNVNDEKYDR(I)  34.39  19.62  561.9497  3  1,682.83  0.3872 
(K)IFSALNVNDEK(Y)  51.35  36.06  625.3251  2  1,248.64  0.4146 
(K)QLTVVNSISIIENR(L)  59.84  59.84  793.4492  2  1,584.88  0.1249 
(K)LTDYLIINTK(K)  52.1  32.57  597.3424  2  1,192.67  ‐0.253 
(K)ETGSQINFYAK(L)  56.08  48.71  629.3087  2  1,256.60  ‐0.7013 
EXP2, putative   Q4YAW8  3B  32 kDa  2 (8%)  4 
(K)IPITDmINILK(K)  45.13  31.46  643.8732  2  1,285.73  ‐0.07535 
(R)SNIFYANITQK(N)  76.46  64.28  649.8409  2  1,297.67  0.4143 
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Supplementary Table 2. The PTEX components are expressed throughout the Plasmodium lifecycle. 
 
PTEX 
component 
P. falciparum1 P. berghei1 P. yoelii1 Expression 
Blood Gametocyte  Mosquito Liver 
HSP101 Pf3D7_1116800 PbANKA_071420 PY05364 Pf2,3,4  
Pb2,6 
Pf4,6 
 
Pf2,4
Pb5,6 
Py2,4
Pb5,6 
PTEX150 Pf3D7_1436300 PbANKA_100850 PY02301 Pf2,3,4  
Pb2,6 
Pf4,6 
 
Pf2,4
Pb5,6 
Pf3 
Py2 
Pb5,6 
EXP2 Pf3D7_1471100 PbANKA_133430 PY05892 Pf2,3,4  
Pb2,6 
Pf4 
Pb6 
Pf2
Pb5,6 
Pf3
Py2,4 
Pb5,6 
PTEX88 Pf3D7_1105600 PbANKA_094130 PY03777 Pf2,3,6 
Pb2,6 
Pf6 Pf2
Pb5 
Pb5 
TRX2 Pf3D7_1345100 PbANKA_135800 PY00586 Pf2,3  
Pb2,6 
Pf4 
Pb6 
Pf2
Pb5,6 
Py2,4
Pb5 
 
1Identification numbers extracted from http://www.plasmodb.org/plasmo/home.jsp  
2Transcription data (Florens et al., 2002; Bozdech et al., 2003; Le Roch et al., 2003; Hall et al., 2005) 
3P. falciparum protein expression data for HSP101 (Fischer et al., 1998; Boucher et al., 2006; de Koning-Ward et al., 2009; Sharma et al., 2011; 
Vaughan et al., 2012)] , PTEX150 (Fischer et al., 1998; Boucher et al., 2006; de Koning-Ward et al., 2009; Sharma et al., 2011; Vaughan et al., 
2012), EXP2 (Fischer et al., 1998; Boucher et al., 2006; de Koning-Ward et al., 2009; Sharma et al., 2011; Vaughan et al., 2012) and TRX2 
(Fischer et al., 1998; Boucher et al., 2006; de Koning-Ward et al., 2009; Sharma et al., 2011; Vaughan et al., 2012) 
4Proteomic data (Florens et al., 2002; Tarun et al., 2008; de Koning-Ward et al., 2009; Silvestrini et al., 2010) 
5Transcription data (this study) 
6Protein expression data (this study) 
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Supplementary Table 3. Oligonucleotides used in this study 
 
Name Region amplified Sequence (5’-3’) 
T34F PbTEX150 cds (NotI, SacII) catgcggccgcgGTGGAAGTGGAAGTGGAAGTG 
T35R PbTEX150 cds (SpeI) cattactagtGGCATATGGTGATAAATCATAGAAC 
T36F PbTEX150 cds (SpeI) CACCATATGCCactagtAATGAAGATAAGGATTTCTCAACA 
T37R PbTEX150 cds (AvrII, PstI) cgactgcagccctaggTTCATCTTCATCTTCATCCTCTGG 
T38F Pb101 cds (SacII) gagccgcgGAATAAGATAATATTATTTGTCGATGAA 
T39R Pb101 cds (SpeI) AGCCactagtCAAAGGCATACCGGAATCTCTT 
T40F Pb101 cds (SpeI) CCGGTATGCCTTTGactagtGGCTCATTATCATTTGAATCATC 
T41R Pb101 cds (AvrII) gaccctaggTGACAATGAAAGGTTAATAACAATGT 
T42F PbTrx2 cds (SacII) gagccgcGGAATAACAACGTTTTGGAGC 
T43R PbTrx2 cds (SpeI) TGTTactagtCCAATCTTGGCATCTTGTTGT 
T44F PbTrx2 cds (SpeI) GCCAAGATTGGactagtAACAAAGCAGCACGGATTATATAA 
T45R PbTrx2 cds (AvrII) gaccctaggTAAATGCTTTCTAATAGTTGATGTTAATTC 
T46F PbPTEX88 cds (SacII) gagccgcggAACAATGATCAAATGTATTATACAGG 
T47R PbPTEX88 cds (SpeI) CATGactagtTTACATTAGGAGATGTTGAAAAATGAT 
T48F PbPTEX88 cds  (SpeI) TCCTAATGTAAactagtCATGTTCAAGTACTTGTCCAAAAG 
T49R PbPTEX88 cds  (AvrII) gaccctaggTTCATGCAAATAGTAACTCATTGTC 
MK13F PbEXP2 cds (SacII) caccccgcggGTGGTTAGCCTTAGAATGTTG 
MK14R PbEXP2 cds (SpeI) atttactagtGTTGTATGCTTATAGGTCGCA 
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MK15F PbEXP2 cds (SpeI) gcatacaacactagtAAATATTGTAAAATGTGACGCATATA 
MK16R PbEXP2 cds (AvrII) gaccctaggAGCCTCATTAGAATCAGTTTCTT 
S1F PbPTEX88 5’ UTR (HindIII) gccaagcttGATAGCTCAATACACACACTTTTGTATTAATA 
S2R PbPTEX88 5’ UTR (SacII) gttccgcggCTTTTCTATCAATTATAACTTGGTAAAT 
S3F PbPTEX88 3’ UTR (EcoRV) gcgatatcGTAACAGATGATGGGTATATCTTT 
S4R PbPTEX88 3’ UTR (EcoRI gccgaattcCCCATCTTTTTTTATTTTCTACCC 
S5F PbTRX2 5’ UTR (ApaI) tagggcccTTCCTAGTAAAATTACGACCTTATC 
S6R PbTRX2 5’ UTR (SacII) gttccgcggCGCTAATATGTGCTTCATGATGA 
T16F PbTRX2 3’ UTR (EcoRI) cgcgaattcGAATAAGCTATGATATTAGGT 
T17R PbTRX2 3’ UTR (SpeI) cgcactagtCAGAGGAGTGTCAACTGGTAT 
S9F PbEXP2 5’ UTR (ApaI) tagggcccGTGGTTAGCCTTAGAATGTTGTT 
S10R PbEXP2 5’ UTR (SacII) gttccgcggGTTGTATGCTTATAGGTCGCATA 
S11F PbEXP2 3’ UTR (EcoRV) gcgatatcGCAAGAAACTGATTCTAATGAGGC 
S12R PbEXP2 3’ UTR (SmaI) tacccgggCATTTAAGCACAAAGTGGCTGTA 
S23F PbHSP101 5’ UTR (ApaI) tagggcccGCTCTTAATGCATTTGCTTTATA 
S24R PbHSP101 5’ UTR (SacII) gttccgcggGCAATGTTCCGTACCATTTCTACT 
S25bF PbHSP101 3’ UTR (EcoRV) gatatcGGCTCATTATCATTTGAATCATCA 
S26bR PbHSP101 3’ UTR (NotI) gcggccgcGTGTTGGTCTAGCTCCTAATTCTG 
S45F PbPTEX88, upstream of 
integration 
GATTCTACTTCTGTACAGGTAATATATATAGGG 
S46R PbPTEX88, downstream of 
integration 
CATTATTTGACCCCAATGACACAG 
S43F PbTRX2, upstream of GAAAACCCTAAACACATTTTGTGC 
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integration 
S44R PbTRX2, downstream of 
integration 
GTGTTAGAAAAGAAGTTAATAATTCG 
S49F PbEXP2, upstream of 
integration 
GTAATGCGTATATTTATTACATATTAGCC 
S50R PbEXP2, downstream of 
integration 
TTCATACATCAACGTTGGCATGTGGC 
O46R PbDHFR 5’ UTR GATGTGTTATGTGATTAATTCATAC 
O47F PbDHFR 3’ UTR ACTGTTATAATTATGTTGTCTCTTC 
O30F T. gondii DHFR-TS ATGCATAAACCGGTGTGTCTGGTC 
O31R T. gondii DHFR-TS GACAGCCATCTCCATCTGGATTC 
MK46F PfPTEX88 cds (NotI,AvrII) caccgcggccgccctaggATGATTTACCAATACATTTTTGTATTAT 
MK47R PfPTEX88 cds (PstI) tctaCTGCAGTTGGTTTTTATTATTTTCATTGCTGT 
HAR Haemagglutinin epitope tag GCATACCCGTACGACGTCCCGG 
O234 PbPTEX150 cds GGAAGTGTTAGTGGTAATGGTAGCG 
T56F EXP2 5’ UTR TTACTGCGGATTCACAATTATTGC 
PbTubulinS PbTubulin TGGAGCAGGAAATAACTGGG 
PbTubulinAS PbTubulin ACCTGACATAGCGGCTGAAA 
DO216F PbTubulin ATGAGAGAAGTAATAAGTATACATGTAGG 
DO217R PbTubulin CTTGTGGTGATGGCCAGCAAC 
PbTRX2F PbTRX2 AGCCCTTTAACAGCATTGAATA 
PbTRX2R PbTRX2 TTCATTACTTGTAACAAAATGCTCA 
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